Results 111 to 120 of about 5,641 (130)

Early screening for liver cancer must be performed. [PDF]

World J Hepatol
Liu ZH, Wang WJ, Dang SS.
europepmc   +1 more source

Effects of yogic practices on physiological and biochemical parameters of hypertensive patients: A systematic review of clinical trials. [PDF]

J Ayurveda Integr Med
Tyagi P, Jain K.
europepmc   +1 more source

Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma. [PDF]

World J Gastroenterol
Villa E, Donghia R, Coletta S, Bonfiglio C, Critelli RM, Ancona A, Shahini E, Iacovazzi PA, Cozzolongo R, Pavone F, Carella N, Pontisso P, Martini A, Al Aoua S, Bantel H, Giannelli G.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients

Clinical Gastroenterology and Hepatology, 2023
The changes in liver stiffness measurement (LSM) are unreliable to estimate regression of fibrosis during antiviral treatment for chronic hepatitis B (CHB) patients. The age-male-albumin-bilirubin-platelets score (aMAP), as an accurate hepatocellular carcinoma risk score, may reflect the liver fibrosis stage.
Rong, Fan, Guanlin, Li, Ning, Yu, Xiujuan, Chang, Tamoore, Arshad, Wen-Yue, Liu, Yan, Chen, Grace Lai-Hung, Wong, Yiyue, Jiang, Xieer, Liang, Yongpeng, Chen, Xiao-Zhi, Jin, Zheng, Dong, Howard Ho-Wai, Leung, Xiao-Dong, Wang, Zhen, Zeng, Terry Cheuk-Fung, Yip, Qing, Xie, Deming, Tan, Shaoli, You, Dong, Ji, Jun, Zhao, Arun J, Sanyal, Jian, Sun, Ming-Hua, Zheng, Vincent Wai-Sun, Wong, Yongping, Yang, Jinlin, Hou   +27 more
openaire   +2 more sources

aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C

Hepatology Research, 2021
AbstractAimsHepatocellular carcinoma (HCC) can still occur in hepatitis C virus (HCV) patients who have achieved a sustained virologic response (SVR), which remains an important clinical issue in the direct‐acting antivirals era. The current study investigated the clinical utility of the aMAP score (consisting of age, male, albumin–bilirubin, and ...
Yuki Yamashita, Satoru Joshita, Ayumi Sugiura, Tomoo Yamazaki, Hiroyuki Kobayashi, Shun‐ichi Wakabayashi, Yosuke Yamada, Soichiro Shibata, Hideo Kunimoto, Takanobu Iwadare, Makiko Matsumura, Chiharu Miyabayashi, Taiki Okumura, Sachie Ozawa, Yuichi Nozawa, Natsuko Kobayashi, Michiharu Komatsu, Naoyuki Fujimori, Hiromi Saito, Takeji Umemura   +19 more
openaire   +2 more sources

[Predictive value of aMAP risk score for early recurrence of small hepatocellular carcinoma after microwave ablation].

Zhonghua nei ke za zhi, 2023
Objective: To explore the value of the aMAP risk score (age, male, albumin-bilirubin, and platelets) to predict early recurrence within one year after microwave ablation in patients with small hepatocellular carcinoma. Methods: This was a retrospective study that enrolled 142 patients diagnosed with hepatocellular carcinoma who were treated with ...
S Y, Dong, S Y, Deng, R, Fan, J Z, Chen, X, Cheng, X, Hao, W C, Dai   +6 more
openaire   +1 more source

The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis

HPB
The aMAP score is a proposed model to predict the development of hepatocellular carcinoma (HCC) among high-risk patients with chronic hepatitis. The role of the aMAP score to predict long-term survival among patients following resection of HCC has not been determined.Patients undergoing resection for HCC between 2000 and 2020 were identified using a ...
Diamantis I. Tsilimigras, Yutaka Endo, Francesca Ratti, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Minoru Kitago, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Ana Gleisner, Feng Shen, Itaru Endo, Timothy M. Pawlik   +17 more
openaire   +2 more sources

[Application of aMAP score to assess the risk of hepatocarciongenesis in population of chronic liver disease in primary hospitals].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021
Objective: The aMAP score is a hepatocellular carcinoma (HCC) risk prediction model based on an international cooperative cohort, which can be applied to various liver diseases. The aim of this study is to use the aMAP score to stratify the risk of HCC in patients with chronic liver disease (combined or non-combined metabolic diseases) admitted to ...
X H, Li, X, Hao, Y H, Deng, X Q, Liu, H Y, Liu, F Y, Zhou, R, Fan, Y B, Guo, J L, Hou   +8 more
openaire   +1 more source

P70 HCC surveillance in a nurse-led clinic: assessing adherence to guidelines and possible role of aMAP score

Poster presentations, 2022
Mohamed Elnagar, Muhammad Saleem, Alison Beard, Samantha Whyld, Andrew Austin   +4 more
openaire   +1 more source

aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in virologically suppressed CHB patients

Journal of Hepatology, 2023
Rong Fan, Guanlin Li, Ning Yu, Xiu-Juan Chang, Tamoore Arshad, Wen-Yue Liu, Yan Chen, Grace Lai-Hung Wong, Yiyue Jiang, Xieer Liang, Yongpeng Chen, Xiao-Zhi Jin, Zheng Dong, Howard Ho-Wai Leung, Xiaodong Wang, Zhen Zeng, Terry Cheuk-Fung Yip, Qing Xie, Deming Tan, Shaoli You, Dong Ji, Jun Zhao, Arun Sanyal, Jian Sun, Ming-Hua Zheng, Vincent Wai-Sun Wong, Yongping Yang, Jinlin Hou   +27 more
openaire   +1 more source